Table 1.
Organelle stress and its phenotypic changes in kidney diseases.
Kidney Disease Pathogenic Phenotypes |
Organelle Dysfunction | Organelle Phenotypic Changes | Ref. |
---|---|---|---|
Acute Kidney Injury (AKI) | |||
Ischemia-reperfusion | Mitochondria | ↑Mitochondrial fission (Fragmentation) ↓ATP production |
[17,18] [17,18] |
Cisplatin | Mitochondria | ↑Mitochondrial DNA-ER-mediated inflammation | [19] |
Chronic Kidney Disease (CKD) | |||
Diabetic glomerular cell damage | Mitochondria | ↑Mitochondrial fission (Fragmentation) | [20] |
Diabetic tubular cell damage | Mitochondria ER ER-Mitochondria |
Aberrant TCA cycle ↑Mitochondrial fission (Fragmentation) ↑Mitochondrial ROS ↓ATP production ↓Lipid β-oxidation ↑Unfolded protein response (UPR) ↓Organelle contact sites (MAM) |
[21,22] [23,24] [23,24] [23,24] [14,25] [25] [25] |
AKI (ischemia-reperfusion)-to-CKD transition | Mitochondria ER- Mitochondria |
↑Mitochondrial fission (Fragmentation) ↓Lipid β-oxidation (lipotoxicity) |
[26] [27] |
Autosomal dominant polycystic kidney disease (ADPKD) | Primary cilia-mitochondria | ↓Glucose metabolism ↓Lipid β-oxidation ↑Mitochondrial ROS ↑Mitochondrial fission (Fragmentation) Impaired Ca homeostasis |
[28] [29,30,31,32] [33,34] [33,34] [35,36] |
ER; endoplasmic reticulum, ROS; reactive oxygen species, MAM; mitochondria-associated ER membranes.